Senate committee advances bill broadening newborn‑screening exemptions

BOISE — The Idaho Senate Health and Welfare Committee on Tuesday voted to send Senate Bill 11 79 to the Senate floor with a “do pass” recommendation, advancing legislation that would move currently administered newborn‑screening rules into state code and broaden the grounds on which parents can opt their newborns out of screening and related interventions.

Sen. Camille Blaylock, a Republican from District 11, introduced the bill as a trailer to Senate Bill 10 14, which previously moved newborn‑screening rules into Idaho law. “These rules govern the tests conducted on infants born in Idaho,” Blaylock said. She told the committee the bill does not add new screening requirements but aligns statutory language with existing practice and expands the exemption language to match the state’s vaccination exemptions.

The issue drew a mix of public‑health testimony and rights‑of‑parents arguments. Jen Beazer, a registered and licensed dietitian who said she has worked in rare‑disease care for 20 years, told the committee Idaho’s newborn blood screening currently looks for about 50 conditions and that early detection typically leads to diagnostic follow‑up and treatment within weeks. “All of these are absolutely life‑saving measures for the infants born with these conditions,” Beazer said, adding that she could not find evidence that the screening test itself causes harm but that failing to screen can lead to irreversible brain damage in some disorders when treatment is delayed.

Matt Lowsby, chair of the Libertarian Party of Idaho, told the committee his organization supports SB 11 79 because it reduces state intrusion into family medical decisions. Quoting his party platform, Lowsby said it is the duty of parents “to act as stewards of their children's natural rights” and that “requirements for particular medical tests and interventions upon children … are a major violation of the parents' right to exercise their own conscience.”

Committee members focused much of their discussion on subsection 2 of the bill, which would allow a physician‑signed certificate stating that a test or intervention would endanger the life or health of the child. Some senators said the clause functions as a medical safeguard backing up parental choice; others and some testifiers said the language could be read broadly and might send a negative signal about the safety or necessity of screening.

Blaylock said the medical‑exemption language mirrors provisions used in vaccine law and is intended to cover clinical situations involving the bundled treatments in the same chapter of code — specifically, the vitamin K injection and eye ointment that often accompany newborn screening. “Because there are treatments looped or bundled in with these screenings … I think it's appropriate to have the medical exemption there,” she said.

Beazer and other testifiers urged that any change include clear informed‑consent language and education for parents explaining what each screen tests for, what a positive screen means (that further diagnostic testing is required) and the potential consequences of delayed diagnosis.

Sen. Keiser moved to send SB 11 79 to the floor with a do‑pass recommendation; Sen. Lenny seconded the motion. The committee approved the motion by voice vote; no roll call tally was recorded in the committee minutes.

The bill is scheduled for consideration on the Senate floor pending scheduling by leadership.

Votes at a glance SB 11 79 — Motion to send to Senate floor with a do‑pass recommendation. Moved by Sen. Keiser; seconded by Sen. Lenny. Outcome: approved by voice vote in committee; no roll‑call tally recorded.